antifibrinolytic

6-Aminocaproic acid (EACA) is an antifibrinolytic agent that acts by inhibiting plasminogen activators which have fibrinolytic properties.

Tranexamic acid (Amstat) is an Antifibrinolytic Agent. The physiologic effect of tranexamic acid is by means of Decreased Fibrinolysis.

Aprotinin (Traskolan) is a broad-spectrum serine protease (BPTI) inhibitor that inhibits the activity of a number of different esterases and proteases. Aprotinin is an antifibrinolytic agent used to minimize hemorrhage during complex surgical procedures.

4-(Aminomethyl)benzoic acid (PAMBA), an antifibrinolytic, is an unnatural amino acid derivative.

CU-2010 is a synthetic serine protease inhibitor with antifibrinolytic and anticoagulant properties. CU-2010 dose-dependently reduces postoperative blood loss and improves postischemic recovery after cardiac surgery in a canine model.

6-Aminocaproic acid hydrochloride, a monoamino carboxylic acid derivative, is a potent, orally active antifibrinolytic agent that inhibits plasmin and plasminogen. It competitively binds to lysine residues on plasminogen, preventing clot lysis by inhibiting plasmin formation and reducing fibrinolysis. This compound is utilized in researching bleeding disorders.

6-Aminocaproic acid-d6 is the deuterated form of 6-Aminocaproic acid (EACA), a monoamino carboxylic acid. This compound acts as an effective and orally active inhibitor of plasmin and plasminogen. It serves as a potent antifibrinolytic agent by competitively binding to lysine residues on plasminogen, preventing clot dissolution, inhibiting plasmin formation, and reducing fibrinolysis. Additionally, 6-Aminocaproic acid is utilized in the study of hemorrhagic disorders.

Tranexamic Acid-13C2-15N is the 13C and 15N labeled compound of Tranexamic Acid. Tranexamic Acid has a CAS number of 1197-18-8. Tranexamic acid is an Antifibrinolytic Agent. The physiologic effect of tranexamic acid is by means of Decreased Fibrinolysis.

6-Aminocaproic acid (Standard) is the standard substance of 6-Aminocaproic acid, and it is applicable for quantitative analysis, quality control, and related research in biochemical experiments. 6-Aminocaproic acid (EACA) is an antifibrinolytic agent that acts by inhibiting plasminogen activators which have fibrinolytic properties.